Novartis announcement

You will have been informed by Novartis that with effect from 1 June 2010 they will withdraw certain products from wholesale distribution and consequently you will need to order these products direct from Novartis through their Patient Priority Supply Service. The ten brands affected are:

Aclasta
Afinator
Exjade
Glivec
Myfortic
Sandimmun
Sandostatin LAR
Tasigna
Tobi
Zometa

All other Novartis products can be ordered from and supplied by AAH in the normal way.

Please remember that your AAH Account Manager is always there to help you select the mix of product - OTC, ethical and generic - which will maximise the benefits to your business.